Central Bank & Trust CO Biogen Inc. Transaction History

Central Bank & Trust CO

  • $701 Million
  • Q1 2024

A detailed history of Central Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Central Bank & Trust CO holds 1,757 shares of BIIB stock, worth $396,467. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,757
Previous 1,826 3.78%
Holding current value
$396,467
Previous $472,000 19.92%
% of portfolio
0.05%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024
SELL
$212.02 - $267.71 $14,629 - $18,471
-69 Reduced 3.78%
1,757 $378,000
Q4 2023

Jan 09, 2024
SELL
$222.59 - $267.94 $54,757 - $65,913
-246 Reduced 11.87%
1,826 $472,000
Q3 2023

Oct 10, 2023
SELL
$253.3 - $285.89 $69,910 - $78,905
-276 Reduced 11.75%
2,072 $532,000
Q2 2023

Jul 13, 2023
SELL
$275.25 - $318.06 $16,239 - $18,765
-59 Reduced 2.45%
2,348 $668,000
Q1 2023

Apr 13, 2023
SELL
$256.56 - $292.34 $20,781 - $23,679
-81 Reduced 3.26%
2,407 $669,000
Q4 2022

Jan 18, 2023
SELL
$252.44 - $306.72 $9,592 - $11,655
-38 Reduced 1.5%
2,488 $0
Q3 2022

Oct 20, 2022
SELL
$194.69 - $268.46 $234,212 - $322,957
-1,203 Reduced 32.26%
2,526 $674,000
Q2 2022

Jul 22, 2022
SELL
$187.54 - $223.02 $209,669 - $249,336
-1,118 Reduced 23.07%
3,729 $760,000
Q1 2022

Apr 18, 2022
SELL
$193.77 - $244.14 $380,564 - $479,490
-1,964 Reduced 28.84%
4,847 $1.02 Million
Q4 2021

Jan 18, 2022
SELL
$223.92 - $287.77 $116,214 - $149,352
-519 Reduced 7.08%
6,811 $1.63 Million
Q3 2021

Oct 19, 2021
SELL
$282.99 - $369.05 $128,760 - $167,917
-455 Reduced 5.84%
7,330 $2.07 Million
Q2 2021

Jul 16, 2021
SELL
$259.0 - $414.71 $118,881 - $190,351
-459 Reduced 5.57%
7,785 $2.7 Million
Q1 2021

Apr 20, 2021
SELL
$242.95 - $284.63 $212,581 - $249,051
-875 Reduced 9.6%
8,244 $2.31 Million
Q4 2020

Jan 12, 2021
BUY
$236.26 - $355.63 $184,755 - $278,102
782 Added 9.38%
9,119 $2.23 Million
Q3 2020

Oct 08, 2020
SELL
$264.77 - $305.71 $19,857 - $22,928
-75 Reduced 0.89%
8,337 $2.37 Million
Q2 2020

Jul 15, 2020
SELL
$258.66 - $342.55 $128,036 - $169,562
-495 Reduced 5.56%
8,412 $2.25 Million
Q1 2020

Apr 14, 2020
BUY
$268.85 - $341.04 $122,326 - $155,173
455 Added 5.38%
8,907 $2.08 Million
Q1 2020

Apr 14, 2020
SELL
$268.85 - $341.04 $32,799 - $41,606
-122 Reduced 1.42%
8,452 $2.67 Million
Q4 2019

Jan 13, 2020
SELL
$220.06 - $304.07 $171,866 - $237,478
-781 Reduced 8.35%
8,574 $2.54 Million
Q3 2019

Oct 23, 2019
BUY
$217.44 - $243.88 $97,413 - $109,258
448 Added 5.03%
9,355 $2.18 Million
Q2 2019

Jul 16, 2019
BUY
$219.29 - $241.72 $167,976 - $185,157
766 Added 9.41%
8,907 $2.08 Million
Q1 2019

Apr 22, 2019
SELL
$216.71 - $338.96 $309,461 - $484,034
-1,428 Reduced 14.92%
8,141 $1.92 Million
Q4 2018

Jan 17, 2019
SELL
$278.5 - $352.75 $219,179 - $277,614
-787 Reduced 7.6%
9,569 $2.88 Million
Q3 2018

Nov 23, 2018
SELL
$293.51 - $383.83 $120,045 - $156,986
-409 Reduced 3.8%
10,356 $3.66 Million
Q2 2018

Jul 17, 2018
BUY
$257.52 - $306.91 $91,677 - $109,259
356 Added 3.42%
10,765 $3.12 Million
Q1 2018

Apr 27, 2018
BUY
$260.13 - $367.91 $38,759 - $54,818
149 Added 1.45%
10,409 $2.85 Million
Q4 2017

Jan 16, 2018
SELL
$307.64 - $344.58 $39,070 - $43,761
-127 Reduced 1.22%
10,260 $3.27 Million
Q3 2017

Oct 13, 2017
BUY
$281.15 - $329.69 $2.92 Million - $3.42 Million
10,387
10,387 $3.25 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Central Bank & Trust CO Portfolio

Follow Central Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email